Indegene

Carlyle Group & Capital Group Reduce Stakes in Indian Healthcare Firms December 4, 2024 The Carlyle Group has sold a 4.3% stake in Healthtech firm Indegene for ₹636 crore. This move marks a significant transaction in the Healthtech sector, showcasing its growing valuation.

Indegene Partners with Microsoft to Integrate Gen AI in Healthcare July 12, 2024 The collaboration, disclosed in a company filing on Thursday, aims to empower global life sciences companies with enterprise-grade GenAI services for faster innovation.

Indegene IPO Subscribed 69.71 times on Closing Day May 10, 2024 Following the closing of the subscription window for the Indegene IPO, all eyes of the investors will now be on the finalization of the shares of healthtech firm Indegene.

Indegene IPO Subscribed 1.67 Times on Day 1 of Bidding May 7, 2024 Indegene’s IPO opened for subscription on May 6th and will close on May 8. The tentative date for the listing of shares on the BSE and NSE is May 13.

Healthtech Firm Indegene’s IPO Opens for Subscription Today May 6, 2024 The price band of the issue has been fixed at INR 430-452. At the upper end, the company plans to raise INR 1,842 Cr through the issue.

C-CAMP & Indegene Partner to Drive Life Science Startups Growth March 21, 2024 Further, this initiative aligns with Indegene’s goal of enabling future-ready healthcare globally.